# Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects

> **NCT04088123** · — · WITHDRAWN · sponsor: **George Washington University**

## Conditions studied

- Thrombosis; Artery

## Interventions

- **DRUG:** Ticagrelor Oral Tablet [Brilinta]

## Key facts

- **NCT ID:** NCT04088123
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-01
- **Primary completion:** 2020-09-23
- **Final completion:** 2020-09-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to commence enrollment at institution, terminated on 9/23/20
- **Last updated:** 2021-10-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088123, "Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04088123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*